Quantitative analysis for Q32 Bio Inc. (QTTB) — Health Care: AI-powered alpha score, Benjamin Graham intrinsic value, ML-based forecast, technical and fundamental signals, and insider activity.
Current Q-Score verdict: Strong Buy (74.0) (grade A). 30 signals analyzed (25 differentiated alt-data).
QTTB stock price is tracked daily for technical and fundamental analysis. The data below shows recent trading activity used in trend analysis, momentum calculation, and entry/exit signals.
| Date | High | Low | Close |
|---|---|---|---|
| 2026-04-29 | $5.88 | $5.38 | $5.50 |
| 2026-05-11 | $5.72 | $5.03 | $5.18 |
| 2026-05-21 | $5.87 | $5.38 | $5.50 |
| 2026-06-03 | $13.10 | $11.53 | $12.19 |
| 2026-06-15 | $13.25 | $11.97 | $12.86 |
| 2026-06-26 | $13.18 | $11.99 | $13.17 |
| 2026-07-09 | $14.43 | $12.31 | $12.59 |
| 2026-07-21 | $15.43 | $14.13 | $15.41 |
| 2026-07-31 | $15.99 | $15.00 | $15.68 |
| 2026-08-12 | $15.60 | $15.11 | $15.37 |
| 2026-08-24 | $16.66 | $15.50 | $16.36 |
| 2026-09-03 | $13.59 | $12.74 | $12.80 |
How Q32 Bio Inc. stacks up against same-sector peers on market capitalization and alpha scores:
| Ticker | Company | Market Cap | Alpha Score |
|---|---|---|---|
| ACET | Adicet Bio, Inc. | $73M | — |
| CYPH | Cypherpunk Technologies Inc. | $72M | 38.0 |
| EQ | Equillium, Inc. | $73M | — |
| RANI | Rani Therapeutics Holdings, Inc. | $71M | — |
View all Health Care stocks by valuation and signals →
Q32 Bio Inc. (QTTB) scores Strong Buy (74.0), and the composite conceals a 82-point disagreement between its dimensions. It is strongest on competitive moat at 98 and valuation at 72, and weakest on technicals at 16. A stock can carry competitive moat that high while technicals sits at 16; the composite averages that tension away, which is why the breakdown is worth reading before the headline number. See Q-Score methodology for how these dimensions are weighted and combined.
| Dimension | Score |
|---|---|
| competitive moat | 98 |
| valuation | 72 |
| analyst consensus | 52 |
| earnings quality | 51 |
| technicals | 16 |
StoQuant analyzes 30 signals (25 alt-data). Alternative data sources (FDA approvals, GitHub activity, SEC filings, App Store ratings) complement traditional financial metrics.
All StoQuant signals are explained in our knowledge base:
Health Care Hub — Top performers and valuation outliers in Health Care
Get daily updates on Q32 Bio Inc. (QTTB): Q-Score changes, insider transactions, forecast shifts, sector rotation, and macroeconomic context. The StoQuant digest curates the most material signals for your watchlist — free, no account required.
See a sample digest • Unsubscribe anytime • Privacy policy
StoQuant is a quantitative stock research platform powered by AI scoring, fundamental analysis, and institutional-grade signals. We cover 3,600+ US-listed equities with daily updates on valuations, earnings quality, insider flow, and ML-based return forecasts. Learn more about us.
Share this stock's latest Q-Score and alpha score on your website, GitHub README, or blog. The SVG badge auto-updates daily:
<a href="https://stoquant.com/research/QTTB"><img src="https://stoquant.com/badge/QTTB.svg" alt="Q32 Bio Inc. (QTTB) Q-Score and Alpha on StoQuant" width="240" height="64" /></a>
StoQuant research is generated algorithmically using public market data, SEC filings, news feeds, and proprietary ML models. Not investment advice. Past performance does not guarantee future results.
Weekly Q-Score signals and insider buying activity on our highest-conviction stock picks. Email only, no account needed. See a sample digest.